Marimed (MRMD) Retained Earnings (2011 - 2026)

Marimed (MRMD) has reported Retained Earnings for 16 consecutive years, with $180.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 0.76% year-over-year to $180.1 million in Q2 2026; TTM through Jun 2026 was $180.1 million, a 0.76% increase from a year earlier, with the FY2025 full-year figure at $179.4 million, up 3.48% from the prior year.
• Retained Earnings was $180.1 million for Q2 2026 at Marimed, roughly flat from $179.7 million in the prior quarter.
• Over five years, Retained Earnings peaked at $180.1 million in Q2 2026 and troughed at $138.1 million in Q1 2022.
• A 5-year average of $166.0 million and a median of $172.1 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings grew 20.66% in 2023 and grew 0.76% in 2026, its largest moves.
• Over 5 years, Retained Earnings stood at $142.4 million in 2022, then gained by 20.21% to $171.1 million in 2023, then grew by 1.3% to $173.4 million in 2024, then rose by 3.48% to $179.4 million in 2025, then increased by 0.36% to $180.1 million in 2026.
• The last three Retained Earnings figures came in at $180.1 million (Q2 2026), $179.7 million (Q1 2026), and $179.4 million (Q4 2025), per Business Quant data.